Axonics Modulation Technologies, Inc., an Irvine, CA-based developer of miniaturized implantable Sacral Neuromodulation technology, completed a $38.5m Series B financing. Backers included new investors Advent Life Sciences and Cormorant Asset Management, and existing investors Edmond de Rothschild Investment Partners, NeoMed…